Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
Xiaowen HouXiaoqiu LiXinhong WangHuisheng ChenPublished in: Stroke and vascular neurology (2018)
NCT02869009; Pre-results.
Keyphrases
- antiplatelet therapy
- open label
- clinical trial
- study protocol
- acute coronary syndrome
- percutaneous coronary intervention
- liver failure
- phase ii
- phase iii
- double blind
- phase ii study
- respiratory failure
- atrial fibrillation
- randomized controlled trial
- high intensity
- aortic dissection
- drug induced
- coronary artery disease
- placebo controlled
- cross sectional
- hepatitis b virus
- squamous cell carcinoma
- intensive care unit
- rectal cancer
- mechanical ventilation